Tolerability and effectiveness of a dermocosmetic product containing Silybum marianum fruit extract in adolescents and young adults with acne‐prone skin: An international, phase IV, longitudinal study
Journal of Cosmetic Dermatology · 2023
DOI: 10.1111/jocd.15705 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Journal of Cosmetic Dermatology, 2023. Verfasst von Foteini Bageorgou und 5 weiteren Autor:innen. Beteiligte Einrichtung: Private Dermatology & Laser Clinic, Athens, Greece. Hauptthemen laut MEDLINE: Acne Vulgaris, Cosmetics. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Pierre Fabre Dermo-Cosmétique.
Abstract (Originalsprache)
Background
Dermocosmetic products are often used to maintain or enhance the tolerance and effectiveness of medical anti‐acne therapies. Recent discoveries about the pathophysiology of acne‐prone skin indicate that skincare products may help maintain homeostasis around the sebaceous gland progenitor cells, thereby preventing microcomedone formation.
Aims
To evaluate the tolerance and effectiveness of a dermocosmetic product containing Silybum marianum fruit extract (SMFE) in adolescents and young adults with acne‐prone skin. Patients/Methods This real‐life, international, observational, multicenter study was conducted in patients aged 12–25 years with mild‐to‐moderate acne. Patients ( N = 4230) used the product twice daily for 8–12 weeks, either alone before (“initial group”) or after an anti‐acne therapy (“maintenance group”), or in association with their usual prescribed anti‐acne therapies (“association group”). The tolerance, effectiveness, and cosmetic properties of the product were assessed. Patient quality of life (QoL) was also evaluated.
Results
Dermatologists rated the tolerance of the product as “good” or “very good” in about 95% of the patients and the effectiveness of the product as “effective” or “highly effective” in about 80% of the patients, with a significant reduction in the mean global evaluation of acne (GEA) grade (−36% ± 39%, p < 0.0001) at study end. The QoL of most patients (80%) improved by the end of the study, and the majority (79% to 94%) appreciated the cosmetic properties of the product. Overall, the product was a clinical success in >84% of patients.
Conclusions
This dermocosmetic product can be used by adolescents and young adults with acne‐prone skin to limit the initial or chronic use of medical anti‐acne therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Private Dermatology & Laser Clinic, Athens, Greece.
- Department of Dermatology, West China Hospital, Sichuan University, Chengdu, China.
- Association France3a, France Acné Ados, Vincennes, France.
- Laboratoires Dermatologiques Avène, Pierre Fabre Dermo-Cosmétique, Lavaur, France.
- University of Geneva, Geneva, Switzerland.
ORCID-Profile: Foteini Bageorgou, Li Li, Jean Hilaire Saurat
Förderung
- Pierre Fabre Dermo-Cosmétique
Zitieren
APA
Bageorgou, F., Li, L., Beausillon, C., Stennevin, A., Ortiz-Brugués, A., & Saurat, J. H. (2023). Tolerability and effectiveness of a dermocosmetic product containing Silybum marianum fruit extract in adolescents and young adults with acne‐prone skin: An international, phase IV, longitudinal study. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.15705
Vancouver
Bageorgou F, Li L, Beausillon C, Stennevin A, Ortiz-Brugués A, Saurat JH. Tolerability and effectiveness of a dermocosmetic product containing Silybum marianum fruit extract in adolescents and young adults with acne‐prone skin: An international, phase IV, longitudinal study. Journal of Cosmetic Dermatology. 2023. doi:10.1111/jocd.15705
BibTeX
@article{Bageorgou2023,
author = {Bageorgou, Foteini and Li, Li and Beausillon, Christopher and Stennevin, Aline and Ortiz-Brugués, Ariadna and Saurat, Jean Hilaire},
title = {Tolerability and effectiveness of a dermocosmetic product containing Silybum marianum fruit extract in adolescents and young adults with acne‐prone skin: An international, phase IV, longitudinal study},
journal = {Journal of Cosmetic Dermatology},
year = {2023},
doi = {10.1111/jocd.15705}
}
EUVIMED